Pablo García-Miranda Selected Research

N-trifluoroacetyladriamycin

1/2021

Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo García-Miranda Research Topics

Disease

4	Colitis 01/2021 - 12/2016
3	Inflammation (Inflammations) 05/2022 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 12/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2017
1	Hydrocephalus (Hydrocephaly) 01/2021
1	Normal Pressure Hydrocephalus 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Polyps 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Dementia (Dementias) 01/2021
1	Ulcerative Colitis 01/2021
1	Neuromyelitis Optica (Devic's Disease) 11/2019
1	Multiple Sclerosis 11/2019
1	Carcinogenesis 01/2017

Drug/Important Bio-Agent (IBA)

4	Messenger RNA (mRNA)IBA 05/2022 - 12/2016
2	Dextran SulfateIBA 05/2022 - 01/2021
2	Dextrans (Dextran)FDA Link 01/2021 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2021 - 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022
1	Aquaporin 4IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	N-trifluoroacetyladriamycinIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Aquaporin 1IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	Aquaporins (Water Channels)IBA 01/2021
1	AntibodiesIBA 11/2019
1	Immunoglobulin G (IgG)IBA 11/2019
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2019
1	Cyclin D1IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	VimentinIBA 01/2017
1	SodiumIBA 01/2017
1	AzoxymethaneIBA 01/2017
1	Extracellular Matrix ProteinsIBA 01/2017

Therapy/Procedure

1	Intraperitoneal Injections 01/2021
1	Oral Administration 01/2021